Fidelis Capital Partners, LLC Astrazeneca PLC Transaction History
Fidelis Capital Partners, LLC
- $702 Billion
- Q2 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 16,013 shares of AZN stock, worth $1.33 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
16,013
Previous 11,081
44.51%
Holding current value
$1.33 Million
Previous $751 Million
71.96%
% of portfolio
0.18%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...